Pharmacology

Action Mechanism of Action Reference
INHIBITOR Programmed cell death protein 1 inhibitor FDA

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Neoplasms 4 D009369 ClinicalTrials
Carcinoma, Squamous Cell 4 D002294 ClinicalTrials
Carcinoma, Squamous Cell 4 D002294 ClinicalTrials
Carcinoma, Non-Small-Cell Lung 3 D002289 ClinicalTrials
Uterine Cervical Neoplasms 3 D002583 ClinicalTrials
Hemangiosarcoma 2 D006394 ClinicalTrials
Prostatic Neoplasms, Castration-Resistant 2 D064129 ClinicalTrials
Glioblastoma 2 D005909 ClinicalTrials
Lymphoma 2 D008223 ClinicalTrials
Oropharyngeal Neoplasms 2 D009959 ClinicalTrials
Melanoma 2 D008545 ClinicalTrials
Pancreatic Neoplasms 2 D010190 ClinicalTrials
Hodgkin Disease 2 D006689 ClinicalTrials
Breast Neoplasms 2 D001943 ClinicalTrials
Diffuse Intrinsic Pontine Glioma 1 D000080443 ClinicalTrials
Skin Neoplasms 1 D012878 ClinicalTrials
Hepatitis B, Chronic 1 D019694 ClinicalTrials
Carcinoma, Merkel Cell 1 D015266 ClinicalTrials
Multiple Myeloma 1 D009101 ClinicalTrials
Neoplasm Metastasis 1 D009362 ClinicalTrials
HIV Infections 1 D015658 ClinicalTrials
Fallopian Tube Neoplasms 1 D005185 ClinicalTrials
Ovarian Neoplasms 1 D010051 ClinicalTrials
Carcinoma, Renal Cell 1 D002292 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL4297723
FDA SRS 6QVL057INT